Ra Capital Management, L.P. Sutro Biopharma, Inc. Call Options Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STRO
# of Institutions
119Shares Held
60.6MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$7.01 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$6.5 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$5.11 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$4.13 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.13MShares$2.95 Million0.01% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $49M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...